Amicus Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Amicus Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 21% to $399,356,000. The net income raised on -$151,584,000 and profit margin reached -38%. Total operating expenses were $427,651,000.
Profit Margin
| 2014 | 1.22M | -68.92M | -5631.21% |
|---|---|---|---|
| 2015 | 0 | -132.11M | |
| 2016 | 4.95M | -200.04M | -4034.73% |
| 2017 | 36.93M | -284.00M | -769.03% |
| 2018 | 91.24M | -348.99M | -382.48% |
| 2019 | 182.23M | -356.38M | -195.56% |
| 2020 | 260.88M | -276.85M | -106.12% |
| 2021 | 305.51M | -250.46M | -81.98% |
| 2022 | 329.23M | -236.56M | -71.85% |
| 2023 | 399.35M | -151.58M | -37.96% |
FOLD Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 399.35M | 329.23M | 305.51M | 260.88M | 182.23M | 91.24M | 36.93M | 4.95M | 0 | 1.22M |
Cost of revenue | 37.32M | 38.59M | 34.46M | 31.04M | 21.96M | 14.40M | 6.23M | 833K | 1.83M | 0 |
Gross profit | 362.03M | 290.63M | 271.04M | 229.84M | 160.27M | 76.84M | 30.69M | 4.12M | -1.83M | 1.22M |
Operating exp. | ||||||||||
Research and development | 152.38M | 276.67M | 272.04M | 308.44M | 286.37M | 270.90M | 149.31M | 104.79M | 76.94M | 47.62M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 427.65M | 495.06M | 470.96M | 473.69M | 461.01M | 402.31M | 241.57M | 179.18M | 126.04M | 69.88M |
Operating income | -73.49M | -204.42M | -199.92M | -243.85M | -300.74M | -328.77M | -441.98M | -181.89M | -130.43M | -68.70M |
Other income (expenses), net | -76.60M | -37.61M | -41.63M | -30.4M | -55.17M | -11.67M | -7.13M | -24.92M | -6.07M | -1.33M |
Income before tax | -150.10M | -242.03M | -241.55M | -274.25M | -355.91M | -349.08M | -449.12M | -203.78M | -132.11M | -70.03M |
Income tax expense | 1.48M | -5.47M | 8.90M | 2.59M | 478K | -94K | -165.11M | -3.73M | 1.49M | -1.11M |
Net income | -151.58M | -236.56M | -250.46M | -276.85M | -356.38M | -348.99M | -284.00M | -200.04M | -132.11M | -68.92M |
Earnings per share | ||||||||||
Basic EPS | -0.51 | -0.82 | -0.92 | -1.07 | -1.48 | -1.88 | -1.85 | -1.49 | -1.2 | -0.93 |
Diluted EPS | -0.51 | -0.82 | -0.92 | -1.07 | -1.48 | -1.88 | -1.85 | -1.49 | -1.2 | -0.93 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |